Supercharge Your Innovation With Domain-Expert AI Agents!

Antibodies binding to nkg2d

A technology for antibodies and binding domains, applied in the field of treating diseases, activating T cells and/or NK cells, producing the antibodies, vectors and host cells, and multispecific antigen-binding molecules

Pending Publication Date: 2022-04-15
F HOFFMANN LA ROCHE & CO AG
View PDF101 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Despite promising clinical results with immune checkpoint inhibitors, only a low proportion of patients respond to these novel therapies

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibodies binding to nkg2d
  • Antibodies binding to nkg2d
  • Antibodies binding to nkg2d

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0765] Example 1. General methods and tools

[0766] recombinant DNA technology

[0767]DNA was manipulated using standard methods, as described in Sambrook, J., et al., Molecular cloning: A laboratory manual; Cold Spring Harbor Laboratory press, Cold spring Harbor, New York, 1989. Molecular biology reagents were used according to the manufacturer's instructions. General information on the nucleotide sequences of human immunoglobulin light and heavy chains is given in the following reference: Kabat, E.A. et al., (1991) Sequences of Proteins of Immunological Interest, Fifth Edition, NIH Publication No 91- 3242.

[0768] DNA sequencing

[0769] DNA sequence was determined by double-strand sequencing.

[0770] gene synthesis

[0771] When required, desired gene segments were generated by PCR using appropriate templates or by automated gene synthesis from synthetic oligonucleotides and PCR products at Geneart AG (Regensburg, Germany). The gene segment flanked by a sing...

example 2

[0776] Example 2. Production of anti-NKG2D antibodies by phage display

[0777] Generating Universal Fab Libraries

[0778] Two universal phage-displayed antibody libraries in Fab format were generated based on human germline genes. The library was randomly distributed among the CDR3 of the light chain (L3) and the CDR3 of the heavy chain (H3) using random primers of different lengths spanning these CDRs, and assembled from 3 fragments by "splicing by overlap extension" (SOE) PCR . After a sufficient number of full-length randomized Fab fragments had been assembled, they were digested with NcoI / Nhel along with similarly treated acceptor phagemid vectors. Fab library inserts were ligated to phagemid vectors, and the purified ligation was used for transformation into E. coli TG1. Phagemid particles displaying the Fab library were rescued using the helper phage VCSM13 and purified by PEG / NaCl purification for selection.

[0779] Selection of anti-NKG2D binders from a univ...

example 3

[0790] Example 3. Production of anti-NKG2D antibodies by immunization of transgenic rabbits

[0791] Animal Care, Rabbit Immunization and Organ Resection

[0792] In addition to the above-mentioned antibodies produced by phage display, other antibodies were also derived from transgenic rabbits expressing humanized antibody libraries after immunization with NKG2D antigen (see, for example, WO 2000 / 46251, WO 2002 / 12437, WO 2005 / 007696, WO2006 / 047367, WO 2007 / 019223 and WO 2008 / 027986, all of which are hereby incorporated by reference in their entirety). Animals were housed in AAALAC-accredited animal facilities according to Appendix A, Guidelines for Housing and Care of Animals. All animal immunization protocols and experiments have been approved by the Government of Upper Bavaria (license number 55.2-1-54-2532-90-14) and were carried out in accordance with the German Animal Welfare Act and Directive 2010 / 63 of the European Parliament and of the Council.

[0793] Using reco...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates generally to antibodies that bind to NKG2D, including multispecific antigen binding molecules, e.g., for activating T cells and / or NK cells. In addition, the invention relates to polynucleotides encoding such antibodies, as well as vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing said antibodies, and to methods of using said antibodies for the treatment of disease.

Description

technical field [0001] The present invention relates generally to antibodies, including multispecific antigen binding molecules, that bind NKG2D, for example for activation of T cells and / or NK cells. Furthermore, the present invention relates to polynucleotides encoding such antibodies, as well as vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing said antibodies, and to methods of using said antibodies for the treatment of diseases. Background technique [0002] Cancer immunotherapy is a very active area of ​​research and is now being used to treat many different types of cancer. Despite promising clinical results with immune checkpoint inhibitors, only a low proportion of patients respond to these novel therapies. This clearly demonstrates that, in addition to checkpoint inhibition, novel differentiated therapeutic approaches to activate the immune system are in high demand to improve clinical benefit for more ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/28C12N15/13A61K39/395A61P35/00
CPCC07K16/2851C07K16/3007A61K2039/505C07K2317/31C07K2317/75C07K2317/92C07K2317/52C07K2317/64C07K2317/66A61P35/00C07K2317/21C07K2317/55C07K2317/73C07K2317/33C07K16/2809C07K2317/565
Inventor S·登格尔G·乔治斯R·霍斯C·克雷恩P·尤马纳I·瓦尔德豪泽
Owner F HOFFMANN LA ROCHE & CO AG
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com